The present invention provides the CP-BMP recombinant proteins with technological merit, it is that it can solve cell/tissue-infiltration and transmission function as the intracellular protein therapy for treating the bony defect as caused by osteogenesis imperfecta, osteoporosis, fracture and osteoctomy.